Clinical Trials Logo

Lymphoblastic Lymphoma clinical trials

View clinical trials related to Lymphoblastic Lymphoma.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT04943952 Approved for marketing - Clinical trials for Acute Lymphoblastic Leukemia

JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase

Start date: n/a
Phase:
Study type: Expanded Access

This study is an Expanded Access Protocol (EAP) of JZP458 in participants with ALL/LBL who are hypersensitive to an E.coli-derived asparaginase (allergic reaction or silent inactivation) and unable to access alternative licensed treatment, to receive JZP458 treatment prior to potential Food and Drug Administration (FDA) approval and commercial availability.